[Haemovigilance in the health care establishment: its role in pediatric transfusion]

J Weiller,A Delbosc,A Greffier

DOI: https://doi.org/10.1016/s1246-7820(03)00099-5

Abstract:Haemovigilance, an important step in transfusion safety, had been set up by a French law in January 1993. Application of haemovigilance in public hospitals is based on three conditions: reporting of adverse transfusion events, traceability of blood products and prevention of adverse transfusion events. The implementation of haemovigilance follows the rules given in a Ministry order dated January 1994, the first of a series including regulations about patient information, virological follow-up of transfused patients, blood product distribution. Haemovigilance rules are the same for adults as for children, concerning blood product traceability and adverse event reporting. It is much more difficult in other fields such as autologous transfusion and "child-patient" information that depend on their parent advice and should be particularly adapted to the familial context, the type of disease and the treatment. Difficulties arise for completing pre- and post-transfusion, immuno-haematologic and virologic controls. Compliance to protocols, in agreement with blood banks, is necessary.